ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global New Chemical Entities (NCE) CDMO Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-36L18770
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global New Chemical Entities NCE CDMO Market Research Report 2025
BUY CHAPTERS

Global New Chemical Entities (NCE) CDMO Market Research Report 2026

Code: QYRE-Auto-36L18770
Report
2026-01-22
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Neuland Laboratories Ltd.
Aspen API
Sai Life Sciences
Fermion
Syngene
Cerbios-Pharma SA
PharmaBlock Sciences (Nanjing), Inc.
KATSURA CHEMICAL CO., LTD
Regis Custom API
Dipharma Francis Srl (Dipharma)
Cohance
Suven Pharma
Aarti Pharmalabs Limited (APL)

New Chemical Entities (NCE) CDMO Market Size

The global New Chemical Entities (NCE) CDMO market was valued at US$ 3242 million in 2025 and is anticipated to reach US$ 6811 million by 2032, at a CAGR of 11.4% from 2026 to 2032.

New Chemical Entities (NCE) CDMO Market

New Chemical Entities (NCE) CDMO Market

New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.
The North American market for New Chemical Entities (NCE) CDMO is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for New Chemical Entities (NCE) CDMO is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for New Chemical Entities (NCE) CDMO in Tumors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of New Chemical Entities (NCE) CDMO include KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global New Chemical Entities (NCE) CDMO market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding New Chemical Entities (NCE) CDMO. The New Chemical Entities (NCE) CDMO market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global New Chemical Entities (NCE) CDMO market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist New Chemical Entities (NCE) CDMO manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of New Chemical Entities (NCE) CDMO Market Report

Report Metric Details
Report Name New Chemical Entities (NCE) CDMO Market
Accounted market size in 2025 US$ 3242 million
Forecasted market size in 2032 US$ 6811 million
CAGR 11.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Peptide NCE
  • Oligonucleotide NCE
  • Other
Segment by Application
  • Tumors
  • Cardiovascular Diseases
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, Aarti Pharmalabs Limited (APL), Cerbios-Pharma SA, PharmaBlock Sciences Nanjing Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for New Chemical Entities (NCE) CDMO companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is New Chemical Entities (NCE) CDMO Market growing?

Ans: The New Chemical Entities (NCE) CDMO Market witnessing a CAGR of 11.4% during the forecast period 2026-2032.

What is the New Chemical Entities (NCE) CDMO Market size in 2032?

Ans: The New Chemical Entities (NCE) CDMO Market size in 2032 will be US$ 6811 million.

Who are the main players in the New Chemical Entities (NCE) CDMO Market report?

Ans: The main players in the New Chemical Entities (NCE) CDMO Market are KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, Aarti Pharmalabs Limited (APL), Cerbios-Pharma SA, PharmaBlock Sciences Nanjing Inc

What are the Application segmentation covered in the New Chemical Entities (NCE) CDMO Market report?

Ans: The Applications covered in the New Chemical Entities (NCE) CDMO Market report are Tumors, Cardiovascular Diseases, Other

What are the Type segmentation covered in the New Chemical Entities (NCE) CDMO Market report?

Ans: The Types covered in the New Chemical Entities (NCE) CDMO Market report are Peptide NCE, Oligonucleotide NCE, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Peptide NCE
1.2.3 Oligonucleotide NCE
1.2.4 Other
1.3 Market by Application
1.3.1 Global New Chemical Entities (NCE) CDMO Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Tumors
1.3.3 Cardiovascular Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Chemical Entities (NCE) CDMO Market Perspective (2021–2032)
2.2 Global New Chemical Entities (NCE) CDMO Growth Trends by Region
2.2.1 Global New Chemical Entities (NCE) CDMO Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 New Chemical Entities (NCE) CDMO Historic Market Size by Region (2021–2026)
2.2.3 New Chemical Entities (NCE) CDMO Forecasted Market Size by Region (2027–2032)
2.3 New Chemical Entities (NCE) CDMO Market Dynamics
2.3.1 New Chemical Entities (NCE) CDMO Industry Trends
2.3.2 New Chemical Entities (NCE) CDMO Market Drivers
2.3.3 New Chemical Entities (NCE) CDMO Market Challenges
2.3.4 New Chemical Entities (NCE) CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue
3.1.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue (2021–2026)
3.1.2 Global New Chemical Entities (NCE) CDMO Revenue Market Share by Players (2021–2026)
3.2 Global Top New Chemical Entities (NCE) CDMO Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by New Chemical Entities (NCE) CDMO Revenue
3.4 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio
3.4.1 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Chemical Entities (NCE) CDMO Revenue in 2025
3.5 Global Key Players of New Chemical Entities (NCE) CDMO Head Offices and Areas Served
3.6 Global Key Players of New Chemical Entities (NCE) CDMO, Products and Applications
3.7 Global Key Players of New Chemical Entities (NCE) CDMO, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 New Chemical Entities (NCE) CDMO Breakdown Data by Type
4.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Type (2021–2026)
4.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2027–2032)
5 New Chemical Entities (NCE) CDMO Breakdown Data by Application
5.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Application (2021–2026)
5.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America New Chemical Entities (NCE) CDMO Market Size (2021–2032)
6.2 North America New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America New Chemical Entities (NCE) CDMO Market Size by Country (2021–2026)
6.4 North America New Chemical Entities (NCE) CDMO Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Chemical Entities (NCE) CDMO Market Size (2021–2032)
7.2 Europe New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2021–2026)
7.4 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size (2021–2032)
8.2 Asia-Pacific New Chemical Entities (NCE) CDMO Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2021–2026)
8.4 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America New Chemical Entities (NCE) CDMO Market Size (2021–2032)
9.2 Latin America New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2021–2026)
9.4 Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size (2021–2032)
10.2 Middle East & Africa New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2021–2026)
10.4 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KATSURA CHEMICAL CO., LTD
11.1.1 KATSURA CHEMICAL CO., LTD Company Details
11.1.2 KATSURA CHEMICAL CO., LTD Business Overview
11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Introduction
11.1.4 KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.1.5 KATSURA CHEMICAL CO., LTD Recent Development
11.2 Regis Custom API
11.2.1 Regis Custom API Company Details
11.2.2 Regis Custom API Business Overview
11.2.3 Regis Custom API New Chemical Entities (NCE) CDMO Introduction
11.2.4 Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.2.5 Regis Custom API Recent Development
11.3 Neuland Laboratories Ltd.
11.3.1 Neuland Laboratories Ltd. Company Details
11.3.2 Neuland Laboratories Ltd. Business Overview
11.3.3 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Introduction
11.3.4 Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.3.5 Neuland Laboratories Ltd. Recent Development
11.4 Aspen API
11.4.1 Aspen API Company Details
11.4.2 Aspen API Business Overview
11.4.3 Aspen API New Chemical Entities (NCE) CDMO Introduction
11.4.4 Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.4.5 Aspen API Recent Development
11.5 Sai Life Sciences
11.5.1 Sai Life Sciences Company Details
11.5.2 Sai Life Sciences Business Overview
11.5.3 Sai Life Sciences New Chemical Entities (NCE) CDMO Introduction
11.5.4 Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.5.5 Sai Life Sciences Recent Development
11.6 Fermion
11.6.1 Fermion Company Details
11.6.2 Fermion Business Overview
11.6.3 Fermion New Chemical Entities (NCE) CDMO Introduction
11.6.4 Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.6.5 Fermion Recent Development
11.7 Dipharma Francis Srl (Dipharma)
11.7.1 Dipharma Francis Srl (Dipharma) Company Details
11.7.2 Dipharma Francis Srl (Dipharma) Business Overview
11.7.3 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Introduction
11.7.4 Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.7.5 Dipharma Francis Srl (Dipharma) Recent Development
11.8 Cohance
11.8.1 Cohance Company Details
11.8.2 Cohance Business Overview
11.8.3 Cohance New Chemical Entities (NCE) CDMO Introduction
11.8.4 Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.8.5 Cohance Recent Development
11.9 Suven Pharma
11.9.1 Suven Pharma Company Details
11.9.2 Suven Pharma Business Overview
11.9.3 Suven Pharma New Chemical Entities (NCE) CDMO Introduction
11.9.4 Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.9.5 Suven Pharma Recent Development
11.10 Syngene
11.10.1 Syngene Company Details
11.10.2 Syngene Business Overview
11.10.3 Syngene New Chemical Entities (NCE) CDMO Introduction
11.10.4 Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.10.5 Syngene Recent Development
11.11 Aarti Pharmalabs Limited (APL)
11.11.1 Aarti Pharmalabs Limited (APL) Company Details
11.11.2 Aarti Pharmalabs Limited (APL) Business Overview
11.11.3 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Introduction
11.11.4 Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.11.5 Aarti Pharmalabs Limited (APL) Recent Development
11.12 Cerbios-Pharma SA
11.12.1 Cerbios-Pharma SA Company Details
11.12.2 Cerbios-Pharma SA Business Overview
11.12.3 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Introduction
11.12.4 Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.12.5 Cerbios-Pharma SA Recent Development
11.13 PharmaBlock Sciences Nanjing Inc
11.13.1 PharmaBlock Sciences Nanjing Inc Company Details
11.13.2 PharmaBlock Sciences Nanjing Inc Business Overview
11.13.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Introduction
11.13.4 PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2021–2026)
11.13.5 PharmaBlock Sciences Nanjing Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Neuland Laboratories Ltd.
Aspen API
Sai Life Sciences
Fermion
Syngene
Cerbios-Pharma SA
PharmaBlock Sciences (Nanjing), Inc.
KATSURA CHEMICAL CO., LTD
Regis Custom API
Dipharma Francis Srl (Dipharma)
Cohance
Suven Pharma
Aarti Pharmalabs Limited (APL)
List of Tables
 Table 1. Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Peptide NCE
 Table 3. Key Players of Oligonucleotide NCE
 Table 4. Key Players of Other
 Table 5. Global New Chemical Entities (NCE) CDMO Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global New Chemical Entities (NCE) CDMO Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global New Chemical Entities (NCE) CDMO Market Size by Region (US$ Million), 2021–2026
 Table 8. Global New Chemical Entities (NCE) CDMO Market Share by Region (2021–2026)
 Table 9. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global New Chemical Entities (NCE) CDMO Market Share by Region (2027–2032)
 Table 11. New Chemical Entities (NCE) CDMO Market Trends
 Table 12. New Chemical Entities (NCE) CDMO Market Drivers
 Table 13. New Chemical Entities (NCE) CDMO Market Challenges
 Table 14. New Chemical Entities (NCE) CDMO Market Restraints
 Table 15. Global New Chemical Entities (NCE) CDMO Revenue by Players (US$ Million), 2021–2026
 Table 16. Global New Chemical Entities (NCE) CDMO Market Share by Players (2021–2026)
 Table 17. Global Top New Chemical Entities (NCE) CDMO Players by Tier (Tier 1, Tier 2, and Tier 3), based on New Chemical Entities (NCE) CDMO Revenue, 2025
 Table 18. Ranking of Global Top New Chemical Entities (NCE) CDMO Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by New Chemical Entities (NCE) CDMO Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of New Chemical Entities (NCE) CDMO, Headquarters and Area Served
 Table 21. Global Key Players of New Chemical Entities (NCE) CDMO, Products and Applications
 Table 22. Global Key Players of New Chemical Entities (NCE) CDMO, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global New Chemical Entities (NCE) CDMO Market Size by Type (US$ Million), 2021–2026
 Table 25. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2021–2026)
 Table 26. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2027–2032)
 Table 28. Global New Chemical Entities (NCE) CDMO Market Size by Application (US$ Million), 2021–2026
 Table 29. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2021–2026)
 Table 30. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2027–2032)
 Table 32. North America New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America New Chemical Entities (NCE) CDMO Market Size by Country (US$ Million), 2021–2026
 Table 34. North America New Chemical Entities (NCE) CDMO Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe New Chemical Entities (NCE) CDMO Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe New Chemical Entities (NCE) CDMO Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America New Chemical Entities (NCE) CDMO Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America New Chemical Entities (NCE) CDMO Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (US$ Million), 2027–2032
 Table 47. KATSURA CHEMICAL CO., LTD Company Details
 Table 48. KATSURA CHEMICAL CO., LTD Business Overview
 Table 49. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product
 Table 50. KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 51. KATSURA CHEMICAL CO., LTD Recent Development
 Table 52. Regis Custom API Company Details
 Table 53. Regis Custom API Business Overview
 Table 54. Regis Custom API New Chemical Entities (NCE) CDMO Product
 Table 55. Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 56. Regis Custom API Recent Development
 Table 57. Neuland Laboratories Ltd. Company Details
 Table 58. Neuland Laboratories Ltd. Business Overview
 Table 59. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product
 Table 60. Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 61. Neuland Laboratories Ltd. Recent Development
 Table 62. Aspen API Company Details
 Table 63. Aspen API Business Overview
 Table 64. Aspen API New Chemical Entities (NCE) CDMO Product
 Table 65. Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 66. Aspen API Recent Development
 Table 67. Sai Life Sciences Company Details
 Table 68. Sai Life Sciences Business Overview
 Table 69. Sai Life Sciences New Chemical Entities (NCE) CDMO Product
 Table 70. Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 71. Sai Life Sciences Recent Development
 Table 72. Fermion Company Details
 Table 73. Fermion Business Overview
 Table 74. Fermion New Chemical Entities (NCE) CDMO Product
 Table 75. Fermion Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 76. Fermion Recent Development
 Table 77. Dipharma Francis Srl (Dipharma) Company Details
 Table 78. Dipharma Francis Srl (Dipharma) Business Overview
 Table 79. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product
 Table 80. Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 81. Dipharma Francis Srl (Dipharma) Recent Development
 Table 82. Cohance Company Details
 Table 83. Cohance Business Overview
 Table 84. Cohance New Chemical Entities (NCE) CDMO Product
 Table 85. Cohance Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 86. Cohance Recent Development
 Table 87. Suven Pharma Company Details
 Table 88. Suven Pharma Business Overview
 Table 89. Suven Pharma New Chemical Entities (NCE) CDMO Product
 Table 90. Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 91. Suven Pharma Recent Development
 Table 92. Syngene Company Details
 Table 93. Syngene Business Overview
 Table 94. Syngene New Chemical Entities (NCE) CDMO Product
 Table 95. Syngene Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 96. Syngene Recent Development
 Table 97. Aarti Pharmalabs Limited (APL) Company Details
 Table 98. Aarti Pharmalabs Limited (APL) Business Overview
 Table 99. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product
 Table 100. Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 101. Aarti Pharmalabs Limited (APL) Recent Development
 Table 102. Cerbios-Pharma SA Company Details
 Table 103. Cerbios-Pharma SA Business Overview
 Table 104. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product
 Table 105. Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 106. Cerbios-Pharma SA Recent Development
 Table 107. PharmaBlock Sciences Nanjing Inc Company Details
 Table 108. PharmaBlock Sciences Nanjing Inc Business Overview
 Table 109. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product
 Table 110. PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (US$ Million), 2021–2026
 Table 111. PharmaBlock Sciences Nanjing Inc Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. New Chemical Entities (NCE) CDMO Picture
 Figure 2. Global New Chemical Entities (NCE) CDMO Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global New Chemical Entities (NCE) CDMO Market Share by Type: 2025 vs 2032
 Figure 4. Peptide NCE Features
 Figure 5. Oligonucleotide NCE Features
 Figure 6. Other Features
 Figure 7. Global New Chemical Entities (NCE) CDMO Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global New Chemical Entities (NCE) CDMO Market Share by Application: 2025 vs 2032
 Figure 9. Tumors Case Studies
 Figure 10. Cardiovascular Diseases Case Studies
 Figure 11. Other Case Studies
 Figure 12. New Chemical Entities (NCE) CDMO Report Years Considered
 Figure 13. Global New Chemical Entities (NCE) CDMO Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global New Chemical Entities (NCE) CDMO Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global New Chemical Entities (NCE) CDMO Market Share by Region: 2025 vs 2032
 Figure 16. Global New Chemical Entities (NCE) CDMO Market Share by Players in 2025
 Figure 17. Global New Chemical Entities (NCE) CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by New Chemical Entities (NCE) CDMO Revenue in 2025
 Figure 19. North America New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America New Chemical Entities (NCE) CDMO Market Share by Country (2021–2032)
 Figure 21. United States New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe New Chemical Entities (NCE) CDMO Market Share by Country (2021–2032)
 Figure 25. Germany New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific New Chemical Entities (NCE) CDMO Market Share by Region (2021–2032)
 Figure 33. China New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America New Chemical Entities (NCE) CDMO Market Share by Country (2021–2032)
 Figure 41. Mexico New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa New Chemical Entities (NCE) CDMO Market Share by Country (2021–2032)
 Figure 45. Israel New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE New Chemical Entities (NCE) CDMO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. KATSURA CHEMICAL CO., LTD Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 49. Regis Custom API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 50. Neuland Laboratories Ltd. Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 51. Aspen API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 52. Sai Life Sciences Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 53. Fermion Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 54. Dipharma Francis Srl (Dipharma) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 55. Cohance Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 56. Suven Pharma Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 57. Syngene Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 58. Aarti Pharmalabs Limited (APL) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 59. Cerbios-Pharma SA Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 60. PharmaBlock Sciences Nanjing Inc Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Chemical Drug CDMO Market Research Report 2024
Global Chemical CDMO Market Research Report 2024
Global Large Molecule Drug Substance CDMO Market Research Report 2024
Global Small Molecules CDMO Services Market Research Report 2024
Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Global Small Molecule Drug CDMO Services Market Research Report 2024
Global Full Service CDMO Market Research Report 2024
Global Contract Dose Manufacturing Market Insights Forecast to 2030
Global Pharmaceutical CDMO Market Research Report 2025
Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biological Drug CDMO Market Research Report 2024
Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Formulation CDMO Services Market Research Report 2024
Global Peptide Drug CDMO Market Research Report 2024
Global New Chemical Entities NCE Market Research Report 2025
Global Microbiome CDMO Market Research Report 2024
Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Active Pharmaceutical Ingredients API CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Specialty Chemicals CDMO Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions